Abstract

Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectively, in patients who have atrial fibrillation. Warfarin is substantially more efficacious (by approximately 40%) than antiplatelet therapy. Absolute increases in major extracranial hemorrhage associated with antithrombotic therapy in participants from the trials included in this meta-analysis were less than the absolute reductions in stroke. Judicious use of antithrombotic therapy importantly reduces stroke for most patients who have atrial fibrillation.

Keywords

MedicineAntithromboticAtrial fibrillationWarfarinStroke (engine)Randomized controlled trialInternal medicineMeta-analysisClinical trialCardiology

Affiliated Institutions

Related Publications

Publication Info

Year
2007
Type
review
Volume
146
Issue
12
Pages
857-867
Citations
4729
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

4729
OpenAlex

Cite This

Robert G. Hart, Lesly A. Pearce, Maria I. Aguilar (2007). Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Annals of Internal Medicine , 146 (12) , 857-867. https://doi.org/10.7326/0003-4819-146-12-200706190-00007

Identifiers

DOI
10.7326/0003-4819-146-12-200706190-00007